Development, Characterization, and Assessment of a Tissue-Engineered Prevascularized Pancreatic Islet Encapsulation Device
Islet transplantation for the purpose of treating insulin-dependent diabetes is currently limited by several factors, most significantly, islet survival post transplantation. In the following dissertation, a tissue-engineered prevascularized pancreatic encapsulating device (PPED) was designed, deve...
Main Author: | Hiscox, Alton |
---|---|
Other Authors: | Williams, Stuart K. |
Language: | EN |
Published: |
The University of Arizona.
2008
|
Subjects: | |
Online Access: | http://hdl.handle.net/10150/196072 |
Similar Items
-
Analyzing whether prevascularizing islet scaffolds improves islet survival in C57 BL/6 mouse models
by: Erdman, Dan
Published: (2020) -
Prevascularization-free Primary Subcutaneous Transplantation of Xenogeneic Islets Co-encapsulated with Hepatocyte Growth Factor
by: Yang, Sin-Yu
Published: (2021) -
Transplantation of Human Pancreatic Endoderm Cells Reverses Diabetes Post Transplantation in a Prevascularized Subcutaneous Site
by: Andrew R. Pepper, et al.
Published: (2017-06-01) -
Low-adhesive Ethylene Vinyl Alcohol-based Packaging to Xenogeneic Islets Encapsulation for Type 1 Diabetes Treatment
by: Yang, Kai-Chiang
Published: (2018) -
Prevascularization promotes endogenous cell-mediated angiogenesis by upregulating the expression of fibrinogen and connective tissue growth factor in tissue-engineered bone grafts
by: Pengzhen Cheng, et al.
Published: (2018-07-01)